Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Jamieson

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Biochemical Pharmacology|October 16, 2012
Characterisation of the roles of ABCB1, ABCC1, ABCC2 and ABCG2 in the transport and pharmacokinetics of actinomycin D in vitro and in vivoChristopher R Hill, David Jamieson, Huw D Thomas, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 11, 2020
Formation of Polarized, Functional Artificial Cells from Compartmentalized Droplet Networks and Nanomaterials, Using One-Step, Dual-Material 3D-Printed MicrofluidicsJin Li, Divesh Kamal Baxani, William David Jamieson, et al.
ACS Applied Materials & Interfaces|March 22, 2017
Temporary Single-Cell Coating for Bioprocessing with a Cationic PolymerRicardo D C Ribeiro, Deepali Pal, David Jamieson, et al.
The Journal of Investigative Dermatology|May 27, 2011
Keratinocyte apoptosis in epidermal remodeling and clearance of psoriasis induced by UV radiationSophie C Weatherhead, Peter M Farr, David Jamieson, et al.
Biochemical Pharmacology|January 15, 2014
Identification of dual DNA-PK MDR1 inhibitors for the potentiation of cytotoxic drug activityEmily Mould, Philip Berry, David Jamieson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphismDavid Jamieson, Kerrie Wilson, Simon Pridgeon, et al.
Oncology Reports|October 4, 2011
The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinideJane L Armstrong, Shaun Martin, Nicola A Illingworth, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2016
Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphomaGareth J Veal, Michael Cole, Girish Chinnaswamy, et al.
AIDS (London, England)|December 24, 2013
Delivering pediatric HIV care in resource-limited settings: cost considerations in an expanded responseMichael A Tolle, B Ryan Phelps, Chris Desmond, et al.
Journal of the International AIDS Society|February 28, 2018
Shortening the decade-long gap between adult and paediatric drug formulations: a new framework based on the HIV experience in low- and middle-income countriesMartina Penazzato, Linda Lewis, Melynda Watkins, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Biochemical Pharmacology|October 16, 2012
Characterisation of the roles of ABCB1, ABCC1, ABCC2 and ABCG2 in the transport and pharmacokinetics of actinomycin D in vitro and in vivoChristopher R Hill, David Jamieson, Huw D Thomas, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 11, 2020
Formation of Polarized, Functional Artificial Cells from Compartmentalized Droplet Networks and Nanomaterials, Using One-Step, Dual-Material 3D-Printed MicrofluidicsJin Li, Divesh Kamal Baxani, William David Jamieson, et al.
ACS Applied Materials & Interfaces|March 22, 2017
Temporary Single-Cell Coating for Bioprocessing with a Cationic PolymerRicardo D C Ribeiro, Deepali Pal, David Jamieson, et al.
The Journal of Investigative Dermatology|May 27, 2011
Keratinocyte apoptosis in epidermal remodeling and clearance of psoriasis induced by UV radiationSophie C Weatherhead, Peter M Farr, David Jamieson, et al.
Biochemical Pharmacology|January 15, 2014
Identification of dual DNA-PK MDR1 inhibitors for the potentiation of cytotoxic drug activityEmily Mould, Philip Berry, David Jamieson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphismDavid Jamieson, Kerrie Wilson, Simon Pridgeon, et al.
Oncology Reports|October 4, 2011
The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinideJane L Armstrong, Shaun Martin, Nicola A Illingworth, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2016
Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphomaGareth J Veal, Michael Cole, Girish Chinnaswamy, et al.
AIDS (London, England)|December 24, 2013
Delivering pediatric HIV care in resource-limited settings: cost considerations in an expanded responseMichael A Tolle, B Ryan Phelps, Chris Desmond, et al.
Journal of the International AIDS Society|February 28, 2018
Shortening the decade-long gap between adult and paediatric drug formulations: a new framework based on the HIV experience in low- and middle-income countriesMartina Penazzato, Linda Lewis, Melynda Watkins, et al.
Pageof 5